机器人辅助步态训练对帕金森病患者的影响:随机对照试验研究方案
本研究为前瞻性、单盲、单中心随机对照试验,拟纳入44例帕金森病患者,随机分配至Walkbot-S™机器人辅助步态训练组或跑台训练组,每周3次、每次45分钟、共4周。主要结局为舒适速度下10米步行测试的步速,次要结局包括双任务干扰、平衡、跌倒效能、冻结步态、运动症状严重程度及静息态功能磁共振功能连接。
要点
- 机器人辅助步态训练与跑台训练强度匹配,以最大速度为目标。
- 主要结局为单任务条件下舒适速度的10米步行测试步速。
- 将评估步态自动性及脑功能网络连接以探索机制。
核心结论
- 该试验将揭示外骨骼机器人辅助步态训练对帕金森病患者步速、步态自动性、平衡、跌倒风险、生活质量和疾病严重程度的影响,并探索其脑功能网络机制。
研究设计与样本
- 前瞻性、单盲、单中心随机对照试验,计划招募44例帕金森病患者,按α=0.05、把握度80%计算样本量。
关键数值与推荐
- 干预为每周3次、每次45分钟、共4周,机器人组和跑台组均以 participant 身高对应的最大速度为训练目标。
- 主要结局为单任务条件下舒适速度的10米步行测试步速,在干预后3天内(T1)评估。
- 次要结局包括双任务干扰、Berg平衡量表、计时起立-行走测试、韩版国际跌倒效能量表、新冻结步态问卷、MDS-UPDRS及静息态功能磁共振功能连接。
- 基线评估(T0)在干预前进行,随访评估(T2)在干预后1个月进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robot-assisted gait training (RAGT) was developed to restore gait function by promoting neuroplasticity through repetitive locomotor training and has been utilized in gait training. However, contradictory outcomes of RAGT have been reported for patients with Parkinson's disease (PD). In addition, the mechanism of the RAGT treatment effect is still unknown. This study aims to investigate the effects of RAGT on gait velocity in patients with PD and to unveil the mechanisms of these effects. METHODS: This is a prospective, single-blind, single-center, randomized controlled trial. Eligible participants will be randomly allocated to: 1) a Walkbot-S™ RAGT group or 2) a treadmill training group. The participants will receive three 45-min sessions of each intervention per week for 4 weeks. Gait speed during RAGT will be targeted to the maximal speed depending on the participant's height; the same principle will be applied to the treadmill training group to match the training intensity. The primary outcome measure is gait speed measured by the 10-Meter Walk Test at a comfortable pace under single-task conditions. Secondary outcomes include dual-task interference, the Berg Balance Scale, Timed Up and Go test, the Korean version of the Falls Efficacy Scale-International, New Freezing of Gait Questionnaire, Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale, and functional connectivity measured by resting-state functional magnetic resonance imaging. Baseline assessments (T0) will be conducted to acquire clinical characteristics and outcome measure values before the intervention. Postintervention assessments (T1) will compare immediate efficacies within 3 days after the intervention. Follow-up assessments (T2) will be conducted 1 month after the intervention. Considering an alpha of 0.05 and a power of 80%, the total number of participants to be recruited is 44. DISCUSSION: This study will reveal the effect of RAGT using an exoskeletal robot, not only on gait speed, but also on gait automaticity, balance function, fall risk, quality of life, and disease severity. In addition, the study will shed new light on the mechanism of the RAGT effect by evaluating changes in gait automaticity and brain functional networks. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03490578 . Registered on 21 March 2018.
引用
- Kang MG, Yun SJ, Shin HI, et al. Effects of robot-assisted gait training in patients with Parkinson's disease: study protocol for a randomized controlled trial. Trials. 2019. PMID: 30616685. doi:10.1186/s13063-018-3123-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。